Camphor toxicity: Difference between revisions
(added reference) |
(ref) |
||
| Line 5: | Line 5: | ||
==References== | ==References== | ||
</ | <references/> | ||
Revision as of 01:35, 22 January 2016
Background
- Common topical agent for pain relief, wart removal, osteoarthritis, cold sores
- FDA limits over the counter preparations to 11%[1]
- Highly lipophilic, widely and rapidly distributed
References
- ↑ United States Food and Drug Administration. Proposed rules: external analgesic drug products for over-the-counter human use; tentative final monograph. Fed Reg 1983